Inhibition of prostacyclin-like material formation by cadmium.
D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects / Q000378:metabolism*; D001241:Aspirin / Q000494:pharmacology; D002104:Cadmium / Q000494:pharmacology*; D011464:Epoprostenol / Q000096:biosynthesis*; D066298:In Vitro Techniques; D008297:Male; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats
D011453:Prostaglandins; D002104:Cadmium; D011464:Epoprostenol; D001241:Aspirin